US Patent Number

8465929

Publication Date

6-18-2013

Abstract

The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer, ovarian cancer of low malignant potential, benign ovarian disease or other malignant condition. The biomarkers can be detected by SELDI mass spectrometry.

Assignees

Vermillion, Inc., Austin, TX (US), The University of Kentucky Research Foundation, Lexington, KY (US)

Application Number

11/922,652

Filing Date

2006-06-23

Included in

Epidemiology Commons

Share

COinS